Diabetes drug reduces risks from steroid treatment

26 Feb 2020


According to a study published in The Lancet Diabetes & Endocrinology, a diabetes drug may reduce the risks from long-term steroid treatment for inflammatory diseases.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story